By Region : North America Europe APAC Latin America MEA Asia Pacific held a sizable revenue share in the global GLP-1 receptor agonist market and is set to witness substantial development by 2032, attributed to the rising prevalence of diabetes driven by factors, such as changing lifestyles, unhealthy diets, and sedentary habits, which is contributing to the increasing demand for effective diabetes management drugs
Wang W, Kou J, Zhang M, Wang T, Li W, Wang Y, et al
A cyclic heptapeptide-based hydrogel boosts the healing of chronic skin wounds in diabetic mice and patients
These reactions help control blood sugar better, lower hunger, and bring about weight loss
A quick, 1-2 minute burst in an ultrasonic water bath works wonders